80 likes | 91 Views
Bioreactors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User (Research and development organizations, Biopharma Manufacturers, Contract Manufacturing Organizations (CMOs)), and Geography
E N D
Bioreactors Market Global Analysis and Forecast to 2028 Published Date : May 2020 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies Bioreactors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User (Research and development organizations, Biopharma Manufacturers, Contract Manufacturing Organizations (CMOs)), and Geography The Bioreactors Market was valued at US$ 2,958.50 million in 2019 and is projected to reach US$5,169.01 million by 2027; it is expected to grow at a CAGR of 7.3% from 2020 to 2027. 2
Email: sales@theinsightpartners.com Bioreactors Market Overview The growth of the bioreactors market is attributed to the increasing research and development activities and rising number of biochemical processes across various domains. Leading companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Merck KGaA, Sartorius AG, PBS Biotech, Inc., General Electric, Bioengineering AG, Cellexus, Danaher (Pall Corporation), and bbi-biotech GmbH, among others. The global bioreactors market, based on molecule, is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy, and others. The monoclonal antibodies segment held the largest share of the market in 2019. However, stem cell segment is estimated to register the highest CAGR in the market during the forecast period. 3
Email: sales@theinsightpartners.com Key Segment Market Segment By Type:- By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Others) Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, Others) Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others) End User (Research and development organizations, Biopharma Manufacturers, Contract Manufacturing Organizations (CMOs)) Download Sample Here 4
Email: sales@theinsightpartners.com $50,000 Bioreactors Market Value $40,000 $30,000 CAGR of 7.3% $20,000 (2020 - 2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles Thermo Fisher Scientific Inc. Pall Corporation (Danaher) Sartorius AG PBS Biotech, Inc. GEA Group Applikon Biotechnology BV Merck KGaA General Electric Company Cellexus bbi-biotech GmbH Other Download Sample Here 6
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com